DDRC SRL DIAGNOSTICS PRIVATE LIMITED
Building No. KMC.II/320B, K.C.Complex,
                                                                               Ground Floor,Ashwini Nagar, Kasaragod - 671121.
                                                                               Mail: kasargod@ddrcsrl.com Phone : 9446425300
                                                                               CIN:U85190MH2006PTC161480
Name :        FATHIMATH AFEEFA PUTHIGE ABDULKUNHI                      Age/Sex :               26/ Female                 SRD No. : CG201755
Doctor :      HARIKRISHNA MBBS MD                                      Sample Collected At : 06-10-2020 12:11 PM          Ref. No. : R1355564
Hospital : COUNTER CASH                                                Report On :    07-10-2020 01:27 PM                 IP/OP No :
  Test Description                                    Value Observed                                       Reference Range
                                                        DEPARTMENT OF GENETICS
 COVID-19 RT PCR
 ________________
 Specimen                                             Nasopharyngeal / oropharyngeal Swab
 E Gene                                               NOT DETECTED
 RdRP/N Gene                                          NOT DETECTED
 Result                                               SARS CoV-2 RNA NOT DETECTED
 Final Report                                         NEGATIVE
Notes:
 ICMR Reg No : DDRCE001
 Test Performed at DDRC SRL, Panampilly Nagar, Ernakulam ICMR approved centre
 Method: Real-time PCR
 This is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in upper and lower respiratory specimens (such
 as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or
 nasal aspirate) collected from individuals who meet 2019-nCoV clinical and/or epidemiological criteria. The assay uses RNA extracted from clinical
 samples. Using the RNA extracted, the assay performs the RT-PCR reaction by dividing it into two assays for accurate detection of SARS-CoV-2. Each
 assay amplifies E gene and the COVID -19 specific target, RdRp gene, if present; thus it is designed for both the screening and specific detection of
 2019-nCoV.
 Pathogen information:
 Coronaviruses are non-segmented positive-stranded RNA viruses with a roughly 30 kb genome surrounded by a protein envelope. Most coronaviruses
 cause diseases in their particular host species; those that can infect humans through cross-species transmission have become an important threat to
 public health. Since December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hasbeen recognised as the causal factor in a
 series of severe cases of pneumonia originating in Wuhan in Hubei province, China. This disease has been named coronavirus disease 2019
 (COVID-19) by WHO.
 Severe acute respiratory syndrome-related coronavirus (SARSr-CoV) is a species of coronavirus that infects humans, bats and certain other mammals.
 It is a member of the genus Betacoronavirus and subgenus sarbecoronavirus. Two strains of the virus have caused outbreaks of severe respiratory
 diseases in humans: SARS-CoV , which caused the 2002-2004 outbreak of severe acute respiratory syndrome (SARS), and SARS-CoV-2, which is
 causing the 2019–20 pandemic of coronavirus disease 2019 (COVID-19). Other strains of Sarbecovirus are only known to infect non-human species:
 bats are a major reservoir of many strains.
 Interpretation:
 Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary
 to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses.
 Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results
 must be combined with clinical observations, patient history, and epidemiological information. A false negative result may occur, if inadequate number of
 organisms are present in the specimen due to improper collection, transport or handling. False negative results may also occur if amplification inhibitors
 are present in the specimen. A single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection.
 Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimens may be
 considered after a gap of 2 – 4 days after the collection of the first specimen for additional testing if required.
Status : FINAL REPORT                              ** End Of Report **
                                                                               Dr. ARPANA V PRABHU                           ANCY ABRAHAM
                                                                                 PhD (Biotechnology)                                MSC
                                                                                  Molecular Geneticist                   Molecular Genetics Division
                                                                           DDRC SRL Panampilly,EKM,Ph-9446508700      DDRC SRL Panampilly,EKM,Ph-9496005100
Page 1 of 1                                                                          Approved By                                 Reviewed By